Collaborated with Elsevier, We recently analyzed the global development of Chinese medicine in the past 10 years. Many interesting trends found:
Rapid expansion: Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023.
High scholarly impact: 14.2% of Chinese Medicine papers ranked among the world’s top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12.
Interdisciplinary breadth: Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science.
Global collaboration hubs: Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications.
Emerging research foci: Top-published trending topics include “Herbaceous Agent | Chinese Medicine | Network Pharmacology” and COVID-19 applications, reflecting integration of omics, AI and systems methods.
Report: https://cm-evaluation.scm.hkbu.edu.hk/
Ref: https://www.eqs-news.com/news/corporate/hong-kong-baptist-university-and...
HIFA Profile: Chris is a physician-scientist engages in integrative clinical services and research of infectious disease (e.g. COVID), respiratory disease (e.g. COPD), metabolic disease (e.g. diabetes), chronic kidney disease, and other internal medicine conditions. Chris is currently the Assistant Professor of the School of Chinese Medicine and Associate Director of the Vincent V.C. Woo Chinese Medicine Clinical Research Institute of HK Baptist University. He is the designer and coordinator of multiple clinical trials, cohorts and biobank. Chris received clinical Chinese medicine training from the HK Baptist University (BCM&BSc) and Guangzhou University of Chinese Medicine (MD); clinical epidemiology, personalized medicine, internal medicine and basic science training from the London School of Hygiene & Tropical Medicine (MSc Public Health), University Medical Center Groningen, Queen Mary Hospital and HKU (PhD). Chris has served for Tung Wah Group of Hospitals, Hospital Authority, World Health Organization and KPMG Advisory on clinical medicine, health administration, medical research and healthcare policy previously.